Medpace (MEDP)
(Delayed Data from NSDQ)
$421.31 USD
-2.65 (-0.63%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $421.05 -0.26 (-0.06%) 7:58 PM ET
1-Strong Buy of 5 1
C Value A Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MEDP 421.31 -2.65(-0.63%)
Will MEDP be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for MEDP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MEDP
Backlog Conversion Likely to Aid Medpace's (MEDP) Q2 Earnings
Top Stocks to Buy for Growth as Earnings Approach
MEDP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Adverum Biotechnologies (ADVM) Stock Outpacing Its Medical Peers This Year?
Medpace Holdings, Inc. (MEDP) Hits Fresh High: Is There Still Room to Run?
SGRY vs. MEDP: Which Stock Is the Better Value Option?
Other News for MEDP
Notable earnings after Monday's close
Medpace Q2 2024 Earnings Preview
Top Stocks To Buy For Growth As Earnings Approach
Medpace Holdings Reaches Analyst Target Price
Peering Into Medpace Hldgs's Recent Short Interest